Drug intelligence / Profile preview

Beni-koji Choleste-Help

Development stage
Discontinued
Lead developer
Kobayashi Pharmaceutical
Modality
Small Molecules, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics
Administration
Oral
01

Overview

Beni-koji Choleste-Help is a dietary supplement developed and manufactured by Kobayashi Pharmaceutical in Japan. The product is formulated with beni-koji, also known as red yeast rice, which is produced by fermenting rice with the fungus Monascus purpureus. Beni-koji contains monacolin K (chemically identical to lovastatin), a compound known for its cholesterol-lowering properties through inhibition of HMG-CoA reductase, similar to prescription statins[6][7][1]. The supplement was marketed for managing cholesterol levels but was recalled in 2024 after being linked to multiple deaths and over 100 hospitalizations due to acute kidney injury. Investigations revealed contamination with puberulic acid—a nephrotoxic compound produced by Penicillium adametzioides during fermentation—as the likely cause of adverse events[3][4][5]. While traditionally used in East Asian cuisine and medicine, modern supplements like Beni-koji Choleste-Help may contain variable amounts of active compounds and potential contaminants.

Brand names
Beni-koji Choleste-Help
Other names
Benikoji Choleste Help
02

Targets

HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)

Beyond the preview

Go deeper on Beni-koji Choleste-Help.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beni-koji Choleste-Help.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call